Psaros Christina, Haberer Jessica E, Boum Yap, Tsai Alexander C, Martin Jeffrey N, Hunt Peter W, Bangsberg David R, Safren Steven A
Department of Psychiatry, Behavioral Medicine Service, Massachusetts General Hospital, One Bowdoin Square, 7th Floor, Boston, MA, 02114, USA,
AIDS Behav. 2015 Jan;19(1):27-33. doi: 10.1007/s10461-014-0796-x.
Depression is one of the most prevalent psychiatric comorbidities of HIV and one of the greatest barriers to HIV self-care and adherence. Despite this, little consensus exists on how to best measure depression among people living with HIV/AIDS (PLWHA) in African settings. Measurement of depression among PLWHA may be confounded by somatic symptoms. Some research recommends excluding these items to enhance measurement validity; sensitivity may be lost with this approach. We sought to characterize depression among a cohort (N = 453) of PLWHA initiating antiretroviral therapy in Uganda via factor analysis of a widely used measure of depression, the Hopkins Symptom Checklist (HSCLD). Common factor analysis was performed, associations between HSCLD and the Mental Health subscale of the Medical Outcomes Study HIV (MOS-HIV) estimated, and a Cronbach's alpha calculated to examine validity. Factor analysis yielded two factors: (1) somatic-cognitive symptoms and (2) behavioral disengagement. Persons with more versus less advanced disease (CD4 cell count of ≤200 cells/mm(3)) showed no statistically significant differences in depression scores (1.7 vs. 1.7, P ≥ 0.5). Both factors were significantly associated with the MOS-HIV (P < .01). Factor one was highly reliable (α = .81); factor two had only modest reliability (α = .65). Somatic-cognitive symptoms of depression and disengagement from life's activities appear to be distinct components of depression in this sample. Consideration of somatic items may be valuable in identifying depression in this setting.
抑郁症是艾滋病毒最常见的精神共病之一,也是艾滋病毒自我护理和坚持治疗的最大障碍之一。尽管如此,在非洲地区如何最好地测量艾滋病毒/艾滋病感染者(PLWHA)的抑郁症方面,几乎没有达成共识。在PLWHA中测量抑郁症可能会受到躯体症状的干扰。一些研究建议排除这些项目以提高测量效度;但这种方法可能会降低敏感性。我们试图通过对一种广泛使用的抑郁症测量工具——霍普金斯症状清单(HSCLD)进行因子分析,来描述乌干达一组开始接受抗逆转录病毒治疗的PLWHA(N = 453)中的抑郁症特征。进行了共同因子分析,估计了HSCLD与医学结局研究艾滋病毒(MOS-HIV)心理健康子量表之间的关联,并计算了克朗巴哈系数以检验效度。因子分析产生了两个因子:(1)躯体-认知症状和(2)行为脱离。疾病进展程度较高(CD4细胞计数≤200个细胞/mm³)与较低的人在抑郁评分上没有统计学上的显著差异(1.7对1.7,P≥0.5)。两个因子均与MOS-HIV显著相关(P<.01)。因子一具有高度可靠性(α =.81);因子二的可靠性一般(α =.65)。在这个样本中,抑郁症的躯体-认知症状和对生活活动的脱离似乎是抑郁症的不同组成部分。在这种情况下,考虑躯体项目可能对识别抑郁症很有价值。